Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) traded down 27.6% on Tuesday . The stock traded as low as GBX 5 ($0.06) and last traded at GBX 10.87 ($0.14). 788,720 shares changed hands during trading, an increase of 216% from the average session volume of 249,443 shares. The stock had previously closed at GBX 15 ($0.19).
Celadon Pharmaceuticals Stock Down 12.9 %
The company has a 50-day moving average of GBX 17.98 and a 200-day moving average of GBX 22.18. The company has a current ratio of 1.92, a quick ratio of 6.97 and a debt-to-equity ratio of 196.67. The company has a market capitalization of £5.07 million, a price-to-earnings ratio of -1.04 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- What is a Special Dividend?
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Most Effectively Use the MarketBeat Earnings Screener
- Qualcomm Stock Is Coiling for a Breakout
- What is Short Interest? How to Use It
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
